HOME >> BIOLOGY >> NEWS
President Bush names Rutgers' Evelyn Witkin for nations highest science honor

NOTE:This release has been updated on 4 November.

NEW BRUNSWICK/PISCATAWAY, N.J. -- President George W. Bush today named Evelyn M. Witkin, Barbara McClintock Professor Emerita at Rutgers, The State University of New Jersey, a recipient of the 2002 National Medal of Science, the nation's highest science and engineering honor.

Witkin, a Princeton resident, is one of eight honorees selected and the 30th woman to receive the medal, which will be presented at a White House ceremony Nov. 6.

"The ideas and breakthroughs in fundamental science and engineering by these extraordinary pioneers have influenced thousands of other researchers," said Rita Colwell, director of the National Science Foundation (NSF). "We now see the daily evidence of the tremendous advancements in technological capabilities, human health and vast new knowledge within our physical world due to these heroes of science we celebrate today," Colwell said.

The National Medal of Science, established by the 86th Congress in 1959 and administered by the NSF, honors the impact of individuals on the present state of knowledge in the physical, biological, mathematical, engineering, social and behavioral sciences. Not including the 2002 recipients, the medal has been awarded to 409 distinguished scientists and engineers, including three previous Rutgers winners.

"The National Medal of Science recognizes the tremendous contributions Evelyn Witkin has made to biological research," said Rutgers President Richard L. McCormick. "It is a mark of personal accomplishment and distinction. Rutgers, her home for two decades, is immensely proud of her achievements."

Witkin was largely responsible for creating the field of DNA mutagenesis and DNA repair, which focuses on how mutations, most of which are unhealthy, occur in DNA and how they may be corrected. Her work, which furthered our understanding of the genetic response to harmful environmental factors such a
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
22-Oct-2003


Page: 1 2 3

Related biology news :

1. AAAS US Presidential Candidates Forum
2. US Presidential Candidates Forum
3. Joslin President awarded medal from international diabetes organization
4. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
5. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
6. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
7. U.S. Presidents budget proposal means 5-year cuts well below historic levels
8. The Presidents FY 2005 budget for USGS highlights
9. Academy Harbor Consortium releases letter on mercury to President Bush
10. President Bush to present DuPont with National Medal of Technology
11. President Bush will honor U.S. science and technology leaders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: